Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OLA1 pseudogene 3 (OLA1P3) is a non-functional DNA sequence on the human genome that shares significant similarity with the functional OLA1 (Obg-like ATPase 1) gene, but does not produce a functional protein. Pseudogenes arise through events such as gene duplication or retrotransposition followed by mutation[4]. Unlike the protein-coding OLA1 gene—which is a member of the GTPase protein family, involved in centrosome regulation, cancer proliferation, and interacts with BRCA1—pseudogenes like OLA1P3 are generally considered genetically inactive and have no direct biological or therapeutic significance[1][4][6][8]. There are no drugs, disease biomarkers, or safety risks associated with OLA1P3 itself. Pseudogenes may occasionally play regulatory roles at the RNA level, but there is no evidence for OLA1P3 having such a function to date[4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on OLA1 pseudogene 3 (OLA1P3).